CONFORMABLE EMBOLIC
Live / Registered — Registered (as of 19 Aug 2025)
What this means for you
Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98719221
- Registration number
- 7908728
- Mark type
- Stylized text
- Filed
- 27 Aug 2024
- Registered
- 19 Aug 2025
- Attorney of record
- Lori A. Ruhly
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for implantable hydrogel-based embolics for treatment of tumors; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems for the treatment of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; pharmaceutical preparations, namely, differentiated liquid embolic agents for embolization of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels
- Class 010 — Medical apparatus: Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for use in embolization surgery; medical device, namely, arterial embolectomy device in the nature of catheters for use in embolectomy; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatus, namely, system for vascular embolization procedures in the nature of catheters for use in embolectomy; pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of artificial materials, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materials, namely, hydrogels; preparations for implantable surgical materials in the nature of implants comprised of artificial materials, namely, hydrogels
Owner
- Boston Scientific Scimed, Inc., Maple Grove, MN, US
- Boston Scientific Scimed, Inc., Maple Grove, MN, US
Prosecution history
- 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 14 Jul 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 14 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 14 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 06 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Mar 2025 — NON-FINAL ACTION E-MAILED
- 07 Mar 2025 — NON-FINAL ACTION WRITTEN
- 03 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Aug 2024 — NEW APPLICATION ENTERED